Naderi M, Hashemi M, Karami H, Moazeni-Roodi A, Sharifi-Mood B, Kouhpayeh H, Taheri M, Ghavami S
Research Center for Infectious Diseases and Tropical Medicine, Zahedan University of Medical Sciences, Iran.
Prague Med Rep. 2011;112(4):272-8.
Approximately 5-10% of subjects infected with Mycobacterium tuberculosis develop active tuberculosis. It has been proposed that genetic factors determine the host's vulnerability to tuberculosis. Chemokine (C-C motif) ligand 2 (CCL2), commonly known as monocyte chemoattractant protein-1 (MCP-1), plays a key role in protective immunity against M. tuberculosis. The present study was aimed to determine if there was an association between -2581 A/G single nucleotide polymorphism of CCL2 and pulmonary tuberculosis (PTB) in a sample of Iranian subjects. This case-control study was performed on 142 PTB and 166 healthy subjects. The polymorphism of CCL2 (rs1024611) was determined using tetra amplification refractory mutational system-polymerase chain reaction (tetra ARMS-PCR). There were no significant differences between PTB patients and control subjects regarding -2581 A/G single nucleotide polymorphism of CCL2. In conclusion, our results do not support an association of -2581 A/G polymorphism of CCL2 with PTB susceptibility.
约5%至10%的结核分枝杆菌感染者会发展为活动性结核病。有人提出,遗传因素决定宿主对结核病的易感性。趋化因子(C-C基序)配体2(CCL2),通常称为单核细胞趋化蛋白-1(MCP-1),在抗结核分枝杆菌的保护性免疫中起关键作用。本研究旨在确定伊朗受试者样本中CCL2基因-2581 A/G单核苷酸多态性与肺结核(PTB)之间是否存在关联。这项病例对照研究对142例PTB患者和166名健康受试者进行。使用四重扩增难治突变系统-聚合酶链反应(tetra ARMS-PCR)检测CCL2(rs1024611)的多态性。CCL2基因-2581 A/G单核苷酸多态性在PTB患者和对照受试者之间没有显著差异。总之,我们的结果不支持CCL2基因-2581 A/G多态性与PTB易感性相关。